摘要:
Provided are a liquid crystalline compound having a wide liquid crystal phase temperature range, low viscosity, a large elastic constant ratio K 33 /K 11 and excellent solubility at low temperature, a liquid crystal composition using the same and a liquid crystal display. Provided is a novel difluorovinyl compound is represented by Formula (1) : wherein Y 1 represents H or a straight chain or branched alkyl group having 1 to 10 carbon atoms, and optional -CH 2 - in the above alkyl group may be replaced by -O-or -CH=CH-, but -O- is not adjacent to each other, and at least one H in Y 1 may be substituted with halogen or a cyano group; A 1 , A 2 , A 3 and A 4 each independently represent 1,4-cyclohexenylene in which optional -CH 2 - which is not adjacent to each other may be replaced by -O-, 1,4-phenylene in which optional H may be substituted with halogen, and a single bond, in which at least two of A 1 , A 2 , A 3 and A 4 have the ring structure described above, and at least one of them is 1,4-cyclohexenylene in which -CH 2 - is replaced by -O-; Z 1 , Z 2 and Z 3 each independently represent a single bond, -(CH 2 ) 2 -, -CH=CH-, -(CH 2 ) 4 -, -O(CH 2 ) 3 - or -(CH 2 ) 3 O-; n represents 0 or an integer of 1 to 10, provided that when any of A 1 , A 2 , A 3 and A 4 is 1,4-phenylene, Z 1 , Z 2 and Z 3 are single bonds, and among them, when A 1 is 1,3-dioxane-2,5-diyl and A 2 is 1,4-phenylene and when A 3 is 1,4-cyclohexylene and A 4 is a single bond, Y 1 is H, and n is not 0.
摘要:
A process for producing hinokitiol which comprises obtaining 1-isopropylcyclopentadiene from cyclopentadiene and an isopropylating agent represented by the general formula R-X (wherein R represents isopropyl; and X represents halogeno, etc.) (the step 1); reacting the obtained product with a dihaloketene to give a ketene-adduct (the step 2); and then decomposing this ketene-adduct (the step 3); wherein the above step 1 involves the following three steps: (a) the step of preparing a cyclopentadienyl metal; (b) the step of isopropylating the cyclopentadienyl metal in an aprotic polar solvent to give isopropylcyclopentadiene; and (c) the step of isomerizing 5-isopropylcyclopentadiene contained in the product selectively into 1-isopropylcyclopentadiene under heating.
摘要:
Alternative methods for synthesizing haloenones and haloalkenes and their use as starting materials for synthesis of substituted or unsubstituted alkyl and aryl substituted enones and alkenes, including tamoxifen and tamoxifen analogs, using such haloenones and haloalkenes.
摘要:
The invention provides compounds of the general formula wherein R represents a hydrogen atom, or an optionally substituted alkyl or acyl group, or an alkenyl or alkynyl group or an inorganic or organic cation;
R 1 represents an alkyl, haloalkyl, alkenyl, alkynyl or phenyl group; R 2 represents an optionally substituted alkyl or phenalkyl group or a cycloalkyl, alkenyl, haloalkenyl, alkynyl or haloalkynyl group; R 3 represents a hydrogen atom or an alkyl group; and one of R 4 and R 5 represents a hydrogen atom or an alkyl group, while the other of R 4 and R 5 represents an optionally substituted phenyl group; together with their use as herbicides and their preparation using novel intermediates.
摘要翻译:本发明提供通式为CHEM的化合物,其中R代表氢原子,或任意取代的烷基或酰基,或烯基或炔基或无机或有机阳离子; R 1表示烷基,卤代烷基,烯基,炔基或苯基; R 2表示任选取代的烷基或苯烷基或环烷基,烯基,卤代烯基,炔基或卤代炔基; R 3表示氢原子或烷基; R 4和R 5中的一个表示氢原子或烷基,R 4和R 5中的另一个表示任选取代的苯基; 以及它们作为除草剂的用途及其使用新型中间体的制备。
摘要:
A method is described of resolving a racemic bicycloheptenone of formula (1) (in which X is a hydrogen, chlorine or bromine atom) which comprises forming an a-hydroxysulphonic acid - chiral amine salt thereof of formula (2) (in which A is the chiral amine), separating the diastereomeric salts and regenerating the bicycloheptenone of formula (1) in optically active form from the separated salt. The resolved bicycloheptenones are useful in the stereospecific synthesis of prostanoids and other substituted cyclopentanones.
摘要:
The present invention relates generally to methods of synthesis of diterpene heterocylic compounds. More particularly, the present invention relates to efficient methods of synthesis of ingenol (Formula (21), CAS 30220-46-3), from a compound of formula (1). The present invention also provides for various advantageous intermediates along the synthetic route of ingenol. Efficient synthesis of ingenol is important in the design and synthesis of related analogues, such as ingenol-3-angelate.
摘要:
Progestines 15,16-Seco-19-nor présentant une activité progestative élevée avec un minimum d'activités hormonales auxiliaires. L'invention concerne également des procédés de préparation des nouvelles progestines ainsi que des modes d'emploi. Un procédé d'utilisation préféré a trait à la suppression de l'ovulation chez la femme.
摘要:
Neue Hydroxyalkyl-azolyl-Derivate der Formel in welcher R, R¹, R², X und Y die in der Beschreibung angegebene Bedeutung haben, sowie deren Säureadditionssalze und Metallsalzkomplexe, mehrere Verfahren zur Herstellung der neuen Stoffe und deren Verwendung als Fungizide und Pflanzenwachstumsregulatoren. Neue Zwischenprodukte, Verfahren zu deren Herstellung und deren Verwendung als Ausgangssubstanzen zur Synthese von Verbindungen der Formel (I).
摘要翻译:新颖的下式的羟基烷基 - 唑基衍生物...其中... R 1,R 2,R 2,X和Y如说明书中所定义,及其酸加成盐和金属盐络合物,a 多种用于制备新物质的方法,以及它们作为杀真菌剂和植物生长调节剂的用途。 新型中间体,它们的制备及其作为合成式(I)化合物的起始物质的用途。
摘要:
Compounds useful in treating cardiovascular disorders such as thrombosis, hypertension and atherosclerosis , in inhibiting gastric acid secretion and in preventing and treating peptic and intestinal ulcers, are depicted in formulas (1), (2) and (3) : wherein:
A is -C≡C-, trans -HC = CH-, -CH 2 CH 2 -or -CH=CHCH 2 -; X is lower alkoxy, hydroxy, or (2,2,2)-trifluoroethoxy; Y is hydrogen, exo-(lower alkyl) or endo-(lower alkyl); n is an integer of 2-4; R 1 is -CH 2 OH, -CHO, -CO 2 R or -COzH, and the olefin formed by the R 1 (CHz) n CH = moiety is either (E) or (Z); R 2 is hydrogen or methyl, or optionally -CH = CH 2 when A is -CH = CHCHr; and R 3 is linear or branched alkyl, alkenyl or alkynyl having 5-10 carbon atoms, , -(CH 2 ) m -phenyl or CH 2 O-phenyl; in which each phenyl may be optionally substituted with lower alkyl, lower alkoxy, trifluoromethyl, or halogen; in which: a is an integer of 0, 1 or 2; b is an integer of 3-7; m is an integer of 0, 1 or 2; and R is wherein X is or
in which each R 4 is independently hydrogen or lower alkyl having 1-6 carbon atoms, and the pharmaceutically acceptable, non-toxic salts and esters thereof.